Articles with public access mandates - Andreas ScorilasLearn more
Not available anywhere: 7
The emergence of drug resistance to targeted cancer therapies: Clinical evidence
AB Sarmento-Ribeiro, A Scorilas, AC Gonçalves, T Efferth, IP Trougakos
Drug Resistance Updates 47, 100646, 2019
Mandates: German Research Foundation, Fundação para a Ciência e a Tecnologia, Portugal …
Computational approaches in cancer multidrug resistance research: Identification of potential biomarkers, drug targets and drug-target interactions
A Tolios, J De Las Rivas, E Hovig, P Trouillas, A Scorilas, T Mohr
Drug Resistance Updates 48, 100662, 2020
Mandates: European Commission
Profilin-1 expression is associated with high grade and stage and decreased disease-free survival in renal cell carcinoma
JR Karamchandani, MY Gabril, R Ibrahim, A Scorilas, E Filter, A Finelli, ...
Human Pathology 46 (5), 673-680, 2015
Mandates: Canadian Institutes of Health Research, Prostate Cancer Canada
Kallikrein-related peptidase 13: an independent indicator of favorable prognosis for patients with nonsmall cell lung cancer
F Gueugnon, A Barascu, K Mavridis, A Petit-Courty, S Marchand-Adam, ...
Tumor Biology 36, 4979-4986, 2015
Mandates: Swiss Cancer League
Discovery and expression analysis of novel transcripts of the human SR-related CTD-associated factor 1 (SCAF1) gene in human cancer cells using Next-Generation Sequencing
PG Adamopoulos, GD Raptis, CK Kontos, A Scorilas
Gene 670, 155-165, 2018
Mandates: US National Institutes of Health
S100A11 is a potential prognostic marker for clear cell renal cell carcinoma
M Gabril, H Girgis, A Scorilas, F Rotondo, S Wala, GA Bjarnason, Q Ding, ...
Clinical & experimental metastasis 33, 63-71, 2016
Mandates: Canadian Institutes of Health Research, Prostate Cancer Canada
Complex transcriptional regulation of the BCL2L12 gene: Novel, active promoter in K562 cells
G Nikcevic, SS Drazilov, TK Djurasevic, N Tosic, CK Kontos, A Scorilas, ...
Gene 750, 144723, 2020
Mandates: Ministry of Education, Science and Technological Development of the Republic …
Available somewhere: 22
Lactate dehydrogenase A is a potential prognostic marker in clear cell renal cell carcinoma
H Girgis, O Masui, NMA White, A Scorilas, F Rotondo, A Seivwright, ...
Molecular cancer 13, 1-10, 2014
Mandates: Canadian Institutes of Health Research, Prostate Cancer Canada
The miR-17-92 cluster is over expressed in and has an oncogenic effect on renal cell carcinoma
TF Chow, M Mankaruos, A Scorilas, Y Youssef, A Girgis, S Mossad, ...
The Journal of urology 183 (2), 743-751, 2010
Mandates: Canadian Institutes of Health Research
The lysine‐specific methyltransferase KMT 2C/MLL 3 regulates DNA repair components in cancer
T Rampias, D Karagiannis, M Avgeris, A Polyzos, A Kokkalis, Z Kanaki, ...
EMBO reports 20 (3), e46821, 2019
Mandates: Worldwide Cancer Research, UK, European Commission
SARS-CoV-2 wastewater surveillance data can predict hospitalizations and ICU admissions
A Galani, R Aalizadeh, M Kostakis, A Markou, N Alygizakis, T Lytras, ...
Science of The Total Environment 804, 150151, 2022
Mandates: US National Institutes of Health
The clinical utility of miR-21 as a diagnostic and prognostic marker for renal cell carcinoma
H Faragalla, YM Youssef, A Scorilas, B Khalil, NMA White, ...
The Journal of Molecular Diagnostics 14 (4), 385-392, 2012
Mandates: Canadian Institutes of Health Research
Prognostic role and implications of mutation status of tumor suppressor gene ARID1A in cancer: a systematic review and meta-analysis
C Luchini, N Veronese, M Solmi, H Cho, JH Kim, A Chou, AJ Gill, SF Faraj, ...
Oncotarget 6 (36), 39088, 2015
Mandates: US National Institutes of Health
Low expression of miR-126 is a prognostic marker for metastatic clear cell renal cell carcinoma
HWZ Khella, A Scorilas, R Mozes, L Mirham, E Lianidou, SN Krylov, ...
The American Journal of Pathology 185 (3), 693-703, 2015
Mandates: Canadian Institutes of Health Research, Prostate Cancer Canada
Galectin-1 has potential prognostic significance and is implicated in clear cell renal cell carcinoma progression through the HIF/mTOR signaling axis
NMA White, O Masui, D Newsted, A Scorilas, AD Romaschin, ...
British journal of cancer 110 (5), 1250-1259, 2014
Mandates: Canadian Cancer Society, Canadian Institutes of Health Research, Prostate …
miR-210 is a prognostic marker in clear cell renal cell carcinoma
S Samaan, HWZ Khella, A Girgis, A Scorilas, E Lianidou, M Gabril, ...
The Journal of Molecular Diagnostics 17 (2), 136-144, 2015
Mandates: Canadian Institutes of Health Research
Microvascular density as an independent predictor of clinical outcome in renal cell carcinoma: an automated image analysis study
VV Iakovlev, M Gabril, W Dubinski, A Scorilas, YM Youssef, H Faragalla, ...
Laboratory investigation 92 (1), 46-56, 2012
Mandates: Canadian Institutes of Health Research
Micro RNA‐194 is a marker for good prognosis in clear cell renal cell carcinoma
R Nofech‐Mozes, HWZ Khella, A Scorilas, L Youssef, SN Krylov, ...
Cancer Medicine 5 (4), 656-664, 2016
Mandates: Canadian Institutes of Health Research, Prostate Cancer Canada
Molecular cloning of novel alternatively spliced variants of BCL2L12, a new member of the BCL2 gene family, and their expression analysis in cancer cells
CK Kontos, A Scorilas
Gene 505 (1), 153-166, 2012
Mandates: US National Institutes of Health
Alpha-enolase is a potential prognostic marker in clear cell renal cell carcinoma
NM White-Al Habeeb, A Di Meo, A Scorilas, F Rotondo, O Masui, ...
Clinical & experimental metastasis 32, 531-541, 2015
Mandates: Canadian Institutes of Health Research, Prostate Cancer Canada
Publication and funding information is determined automatically by a computer program